Diabetes, Obesity and Metabolism Now
Latest Publications

TOTAL DOCUMENTS

25

(FIVE YEARS 0)

H-INDEX

0

(FIVE YEARS 0)

Published By Wiley

2688-8939, 2688-8939

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Sustained reduction in delaying type 1 diabetes with teplizumab

Diabetes, Obesity and Metabolism Now ◽

10.1002/doi2.00023 ◽

2020 ◽

Author(s):

Iskandar Idris

Keyword(s):

Type 1 Diabetes ◽

Sustained Reduction

ADA 2020: Dapagliflozin may help reduce onset of type 2 diabetes

Diabetes, Obesity and Metabolism Now ◽

10.1002/doi2.00020 ◽

2020 ◽

Author(s):

Iskandar Idris

Keyword(s):

Type 2 Diabetes

ADA 2020: Ertugliflozin shown to significantly reduce heart failure hospitalization

Diabetes, Obesity and Metabolism Now ◽

10.1002/doi2.00024 ◽

2020 ◽

Author(s):

Iskandar Idris

Keyword(s):

Heart Failure ◽

Heart Failure Hospitalization

ADA 2020: FreeStyle Libre system initiation provides dramatic drop in diabetic ketoacidosis rates

Diabetes, Obesity and Metabolism Now ◽

10.1002/doi2.00022 ◽

2020 ◽

Author(s):

Iskandar Idris

Keyword(s):

Diabetic Ketoacidosis ◽

Freestyle Libre

COVID‐19: An opportunity to make long‐term improvement changes to inpatient diabetes services

Diabetes, Obesity and Metabolism Now ◽

10.1002/doi2.00026 ◽

2020 ◽

Author(s):

Iskandar Idris

Keyword(s):

Inpatient Diabetes

ADA 2020: Telehealth improves glycaemic control among rural diabetes patients

Diabetes, Obesity and Metabolism Now ◽

10.1002/doi2.00021 ◽

2020 ◽

Author(s):

Iskandar Idris

Keyword(s):

Glycaemic Control ◽

Diabetes Patients

Dapagliflozin significantly prolongs survival in CKD patients

Diabetes, Obesity and Metabolism Now ◽

10.1002/doi2.00025 ◽

2020 ◽

Author(s):

Iskandar Idris

Experimental drug shown to reduce adverse effects of Rosiglitazone

Diabetes, Obesity and Metabolism Now ◽

10.1002/doi2.00019 ◽

2020 ◽

Author(s):

Iskandar Idris

Keyword(s):

Adverse Effects ◽

Experimental Drug

Early evidence for a GLP‐receptor antagonist for the pharmacological management of post bariatric surgery reactive hypoglycaemia

Diabetes, Obesity and Metabolism Now ◽

10.1002/doi2.00014 ◽

2020 ◽

Author(s):

Iskandar Idris

Keyword(s):

Bariatric Surgery ◽

Receptor Antagonist ◽

Pharmacological Management ◽

Early Evidence ◽

Reactive Hypoglycaemia ◽

Post Bariatric Surgery

Study dissecting COVID‐19 related mortality in people with Type 1 and Type 2 diabetes

Diabetes, Obesity and Metabolism Now ◽

10.1002/doi2.00018 ◽

2020 ◽

Author(s):

Iskandar Idris

Keyword(s):

Type 2 Diabetes ◽

Related Mortality